Research progress in the diagnosis and treatment of post-streptococcal reactive arthritis
10.3760/cma.j.cn101070-20240807-00497
- VernacularTitle:链球菌感染后反应性关节炎诊疗研究进展
- Author:
Chenyu ZHANG
1
;
Dandan FENG
1
;
Guoping ZHOU
1
Author Information
1. 南京医科大学第一附属医院儿科，南京 210029
- Publication Type:Journal Article
- Keywords:
Post-streptococcal reactive arthritis;
Group A streptococcus;
Clinical feature;
Treatment
- From:
Chinese Journal of Applied Clinical Pediatrics
2025;40(6):473-477
- CountryChina
- Language:Chinese
-
Abstract:
Post-streptococcal reactive arthritis (PSRA) refers to monoarthritis or polyarthritis that develops secondary to streptococcal infection.PSRA presents similar symptoms to acute rheumatic fever (ARF) but does not meet the diagnostic criteria for ARF.PSRA was classified as the ARF spectrum previously, but an increasing number of reports have shown recently that they are two diseases different in diagnosis, treatment and prognosis.Nowadays, the understanding of PSRA has been improved, but no complete diagnostic guideline is developed.It is hard to differentiate PSRA from ARF and reactive arthritis in clinical diagnosis.There is also controversy about whether antibiotics are needed for long-term preventive treatment, and there is still a lack of research on PSRA in China.In order to provide a reference for domestic research, the clinical features of PSRA and the progress in PSRA diagnosis and treatment are reviewed in this article.
